197
Participants
Start Date
February 28, 2003
Study Completion Date
December 31, 2003
valdecoxib
valdecoxib 20 mg tablet by mouth twice daily (BID) for 2 doses over a 24-hour period
valdecoxib
valdecoxib 40 mg tablet by mouth once daily (QD) for 2 doses over a 24-hour period
placebo
placebo tablet by mouth for 2 doses over a 24-hour period
Pfizer Investigational Site, Boca Raton
Pfizer Investigational Site, Storrs
Lead Sponsor
Pfizer
INDUSTRY